Analysis
PepsiCo (PEP) expects snacks business to remain resilient in the near term
PepsiCo Inc. (NASDAQ: PEP) reported first quarter 2021 earnings results on Thursday that topped expectations on both the...
Analysis
Expert equity analysis, earnings previews, and data-driven market research.
Latest Research
1,807 articles
Analysis
For Wells Fargo (WFC), Q1 sets the stage for long-term recovery
Emerging from the slowdown caused by coronavirus, the financial services sector entered fiscal 2021 on a bright note,...
Analysis
Top 3 Artificial Intelligence stocks you may consider in 2021
Artificial Intelligence has become an integral part of the US economy. According to the analyst’s insights, AI market...
Analysis
US pre-market news: Dow Jones, NASDAQ, S&P updates for Apr.15, 2021
U.S. stocks finished mostly lower on Thursday as the Federal Reserve’s Beige Book showed growth and inflation picking...
Analysis
The worst seems to be over for Boston Scientific. Is the stock a buy?
The pandemic has had a mixed impact on the healthcare sector since its outbreak more than a year...
Analysis
Two areas that provide Pfizer (PFE) with ample opportunity for future growth
Shares of Pfizer Inc. (NYSE: PFE) have gained over 8% in the past one year. Pfizer is at...
ADVERTISEMENT
Analysis
Should you invest in Snowflake (SNOW) stock during the dip?
Snowflake Inc. (NYSE: SNOW) has seen its customer base growing steadily since going public a few months ago....
Analysis
US pre-market news: Dow Jones, NASDAQ, S&P updates for Apr. 14, 2021
US stocks are expected to move up on Wednesday, with investors cautious as the earnings season starts. First-quarter...
Analysis
Pinduoduo (PDD): This could be a decent investment candidate to consider
Shares of Pinduoduo Inc. (NASDAQ: PDD) stayed in green territory on Tuesday. The stock has gained 212% over...
Analysis
Tech stocks to buy at the dip
The technology sector contributes around $1.9 trillion, or 10% of the total US economy. Technology stocks have already...
Analysis
It’s worth keeping an eye on Vertex Pharma (VRTX) stock. Here’s why
After dominating the cystic fibrosis market for quite some time, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) is currently expanding...
Analysis
US pre-market news: Dow Jones, NASDAQ, S&P updates for Apr.13, 2021
Futures of the S&P and the Dow opened higher on Tuesday ahead of inflation data which is all set to...